CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
CoreMap has raised $37.0M in total funding. The most recent round was Series C. The last funding was announced in July 2026.
CoreMap's investors include National Science Foundation, Medtronic, Minnow Ventures, Qure Ventures, Russ Scully.
CoreMap is headquartered in Burlington, United States.
CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
CoreMap is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CoreMap — Funding & Investors." VCBacked, July 29, 2026, https://www.vcbacked.co/company/coremap. Accessed September 30, 2026.
VCBacked. (2026). CoreMap — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/coremap
{{cite web |title=CoreMap — Funding & Investors |url=https://www.vcbacked.co/company/coremap |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated